Biggest News Aggregation in the World
📰 Augmedix Prep News

Augmedix Prep News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Augmedix Prep. Real-time updates on events, politics, business and more.

Millrace Asset Group Inc. Has $1.19 Million Position in Augmedix, Inc. (NASDAQ:AUGX)

Millrace Asset Group Inc. decreased its holdings in shares of Augmedix, Inc. (NASDAQ:AUGX – Free Report) by 40.1% in the 4th quarter, HoldingsChannel reports. The firm owned 203,087 shares of the company’s stock after selling 135,745 shares during the period. Millrace Asset Group Inc.’s holdings in Augmedix were worth $1,188,000 as of its most recent […]
United States Mian Shakil Maxim Group Millrace Asset Group Inc Russell Investments Group Ltd Acadian Asset Management
Source: wkrb13.com

Augmedix, Inc. (NASDAQ:AUGX) Stock Position Reduced by Millrace Asset Group Inc.

Millrace Asset Group Inc. trimmed its position in Augmedix, Inc. (NASDAQ:AUGX – Free Report) by 40.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 203,087 shares of the company’s stock after selling 135,745 shares during the quarter. Millrace Asset Group Inc. owned approximately […]
United States Mian Shakil Millrace Asset Group Inc Russell Investments Group Ltd Maxim Group Perkins Capital Management Inc

Comparing Augmedix (NASDAQ:AUGX) and Micromobility.com (NASDAQ:MCOM)

Augmedix (NASDAQ:AUGX – Get Free Report) and Micromobility.com (NASDAQ:MCOM – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Volatility and Risk Augmedix has a beta of 0.03, […]
New York United States San Francisco Augmedix Inc Get Free Report Given Augmedix

Augmedix (NASDAQ:AUGX) Downgraded by Evercore ISI

Evercore ISI lowered shares of Augmedix (NASDAQ:AUGX – Free Report) from an outperform rating to an inline rating in a report issued on Tuesday, MarketBeat reports. They currently have $1.50 price objective on the stock, down from their prior price objective of $5.00. Other research analysts also recently issued reports about the stock. Maxim Group […]
United States Mian Shakil Worth Venture Partners Sg Americas Securities Acadian Asset Management Maxim Group

Augmedix (NASDAQ:AUGX) Rating Lowered to Hold at Maxim Group

Maxim Group lowered shares of Augmedix (NASDAQ:AUGX – Free Report) from a buy rating to a hold rating in a report issued on Tuesday, Marketbeat Ratings reports. The brokerage currently has $5.00 target price on the stock. A number of other equities analysts also recently commented on AUGX. B. Riley started coverage on shares of […]
United States Mian Shakil Securities Exchange Commission Jump Financial Maxim Group Augmedix Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Augmedix, Inc. (NASDAQ:AUGX) Insider Sells $97,377.54 in Stock

Augmedix, Inc. (NASDAQ:AUGX – Get Free Report) insider Ian Shakil sold 24,778 shares of the firm’s stock in a transaction dated Thursday, April 11th. The shares were sold at an average price of $3.93, for a total value of $97,377.54. Following the completion of the sale, the insider now owns 3,000 shares of the company’s […]
United States Mian Shakil Augmedix Company Profile Legato Capital Management Tucker Asset Management Augmedix Inc

Ian Shakil Sells 37,780 Shares of Augmedix, Inc. (NASDAQ:AUGX) Stock

Augmedix, Inc. (NASDAQ:AUGX – Get Free Report) insider Ian Shakil sold 37,780 shares of the business’s stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $3.97, for a total value of $149,986.60. Following the transaction, the insider now owns 3,000 shares in the company, valued […]
United States Mian Shakil Vontobel Holding Ltd Augmedix Company Profile Portside Wealth Group Augmedix Inc

Evercore ISI Upgrades Augmedix (NASDAQ:AUGX) to Outperform

Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a report issued on Tuesday, Benzinga reports. The firm presently has a $5.00 price objective on the stock, up from their previous price objective of $4.50. Evercore ISI’s target price indicates a potential […]
United States Mian Shakil Augmedix Company Profile Securities Exchange Commission Verition Fund Management Symmetry Peak Management

Evercore ISI Upgrades Augmedix (NASDAQ:AUGX) to Outperform

Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a report issued on Tuesday, Benzinga reports. The firm presently has a $5.00 price objective on the stock, up from their previous price objective of $4.50. Evercore ISI’s target price indicates a potential […]
United States Mian Shakil Worth Venture Partners Thompson Davis Securities Exchange Commission Augmedix Company Profile
Source: wkrb13.com

Evercore ISI Upgrades Augmedix (NASDAQ:AUGX) to Outperform

Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by investment analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a research report issued on Tuesday, Benzinga reports. The brokerage presently has a $5.00 target price on the stock, up from their previous target price of $4.50. Evercore ISI’s price objective indicates […]
United States Mian Shakil Worth Venture Partners Northern Trust Corp Vontobel Holding Ltd Augmedix Company Profile

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science